CGRP monoclonal antibody antagonist

This page covers all CGRP monoclonal antibody antagonist drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting Calcitonin gene-related peptide (CGRP).

Targets

Calcitonin gene-related peptide (CGRP)

Marketed (1)

• erenumab-aooe · Amgen · Neurology
  Erenumab is a monoclonal antibody that binds to and blocks calcitonin gene-related peptide (CGRP), a neuropeptide involved in migraine pathogenesis.

Patent intelligence

• cgrp monoclonal antibody antagonist patent landscape — aggregated cliff calendar, attackable patents, originator estates